 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
! j$ O+ ~7 I& q' V
7 A; I8 `0 y8 \: t0 r8 A; wEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.7 m# G6 W& T: {, y2 y$ X6 }* H2 Q
6 g; a3 M& K9 w2 Y! c. L+ a: \BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
0 P5 l2 ~3 i( E% |% W$ y+ } 7 H* R& f! M( r& j! I: F
3 V3 ?* ^8 x. g, }
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
5 n% g( A' D+ @8 D c" o- a! L4 Z: `+ {9 G; a: O4 G
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."5 N, e1 [! A- x4 U' U# s d/ l
: C' B$ u0 {# f
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.7 f1 y7 ~/ F/ I" i7 `3 {* j, Y
0 {' W, [! D( Q& a l6 mIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.# ?8 a& d) L1 |' n: t$ u# K
4 K: a% j8 R ~. s7 O1 tIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
+ A5 N6 z( q$ G6 U, k+ h/ U- ~# Y2 p+ C+ Z2 u
"As a scientist, it's one of the highlights of my CAREER," Shan said.
$ X" b5 L# r) z4 n1 @% ]% u, j
) K9 @- \5 M# c"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
0 f0 K* S) N# u" y3 ]& \- _" ~1 {8 ~ e( S" ]2 O
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
5 a) U- W2 L& y' P& E' A. J. I# A$ |7 b
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.0 x' G3 Q" T0 {& r
: s' |2 o0 X+ x2 j$ ^ Y, L
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
, n' {& z; ~3 V8 E; \6 `+ e) _: x/ X( S! ?
/ f' W( O6 _, R' V& L. `7 x# Lhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
* I' ]. Y; r* o! y
发表于 2015-2-28 19:45
